Illumina (ILMN) Reports Strong Q1 2026 Earnings Performance
Illumina reported better-than-expected results for Q1 2026, with revenue, margin, and EPS exceeding guidance. The company attributed its strong performance to disciplined execution and growth in clinical markets.
Tickers: $ILMN
Topics: earnings executive commentary financial performance guidance revenue